Part 4: Myelodysplastic syndromes— reatment of low-risk patients with the 5q deletion
Hematol., Transfus. Cell Ther. (Impr.)
; 40(3): 274-277, July-Sept. 2018.
Article
in En
| LILACS
| ID: biblio-953839
Responsible library:
BR408.1
Localization: BR408.1
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Thalidomide
/
Myelodysplastic Syndromes
/
Erythropoietin
/
Gene Deletion
/
Lenalidomide
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2018
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil